首页> 外文OA文献 >Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery
【2h】

Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery

机译:洛哌丁胺胶囊脂质体凝胶体外透析释放方法的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: The purpose of this study was to determine the most appropriate dialysis equilibrium method to assess liposomal gel formulations containing hydrophobic drugs, to give the most accurate indication of drug release. Methods: Loperamide hydrochloride-encapsulated liposomes, composed of L-a-phosphatidylcholine and cholesterol (molar ratio of 2:1), were prepared according to the method of dried lipid film hydration. The liposomes were incorporated into a carbopol gel (0.5%, weight/weight). The release of the drug from the nanoparticles was assessed using a number of variations of the dialysis technique, taking into account solubility parameters and formulation. Method 1 (below saturation point) and Method 2 (above saturation point) used a dilution method to evaluate how drug concentration and solubility affects the in vitro drug-release profile of loperamide hydrochloride, while Methods 3 (below saturation point) and 4 (above saturation point) evaluated how drug concentration and the gel base affect the release profile. Results: In Method 1, the liposomes showed a rapid release of just over 60% in the first 3 hours and then a slower, sustained release to just over 70% at 24 hours. Method 2 showed a gradual, sustained release profile with the liposomes with 55% release at 24 hours. In Method 3, the liposomes showed a rapid burst release of 98% at 2 hours. In Method 4, the liposomal gel had a rapid release of 60% within 3 hours and then a more gradual, sustained release with 86% release at 24 hours. The free drug suspension in Methods 2 and 4 showed a limited release across the dialysis membrane, in comparison to Methods 1 and 3, which showed a complete release in a timely manner. Conclusion: This study has demonstrated that the actual method used for equilibrium dialysis plays a significant role in determining the true characteristics of a topical nanoformulation, with Method 3 providing the most accurate indication of the release of a hydrophobic drug from a topical liposomal formulation.
机译:背景:本研究的目的是确定最合适的透析平衡方法,以评估包含疏水性药物的脂质体凝胶制剂,从而最准确地指示药物释放。方法:按照脂质膜干水化的方法制备盐酸洛哌丁胺包裹的脂质体,该脂质体由L-α-磷脂酰胆碱和胆固醇组成(摩尔比为2:1)。将脂质体掺入卡波姆凝胶(0.5%,重量/重量)中。考虑到溶解度参数和制剂,使用多种透析技术来评估药物从纳米颗粒的释放。方法1(低于饱和点)和方法2(高于饱和点)使用稀释法评估药物浓度和溶解度如何影响盐酸洛哌丁胺的体外药物释放曲线,而方法3(低于饱和点)和方法4(高于饱和点)饱和点)评估了药物浓度和凝胶基质如何影响释放曲线。结果:在方法1中,脂质体在最初的3小时内显示出超过60%的快速释放,然后在24小时内显示出仅超过70%的缓慢而持续的释放。方法2显示了脂质体的逐步缓释曲线,并在24小时释放了55%。在方法3中,脂质体在2小时后显示出98%的快速爆发释放。在方法4中,脂质体凝胶在3小时内快速释放60%,然后逐渐释放,在24小时内释放86%。与方法1和3适时完全释放相比,方法2和4中的游离药物悬浮液在整个透析膜上显示出有限的释放。结论:这项研究表明,用于平衡透析的实际方法在确定局部纳米制剂的真实特征方面起着重要作用,方法3提供了从局部脂质体制剂中释放疏水性药物的最准确指示。

著录项

  • 作者

    Hua, Susan;

  • 作者单位
  • 年度 2014
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号